GlassScriptPhysician profile
Satish Sivasankaran
NPI 1265520043
$4,021.60
in general payments reported to CMS, 2019-2025
28 companies · $771 in 2025
The $771 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $411 · 2021: $556 · 2022: $568 · 2023: $617 · 2024: $546 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,934.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $630.17 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $434.17 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $422.12 | 2019-2023 | Farxiga |
| Pfizer INC. | $317.42 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $255.03 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $253.54 | 2019-2025 | |
| Abbott Laboratories | $241.19 | 2019-2025 | Supera, Perclose Proglide, Absolute Pro |
| Amarin Pharma, INC. | $233.65 | 2019-2021 | |
| Amgen INC. | $172.93 | 2022-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.27 | 2023-2025 | Jardiance |
| Abiomed | $143.43 | 2019-2025 | |
| Boston Scientific Corporation | $127.71 | 2022-2025 | Watchman Flx |
| Edwards Lifesciences Corporation | $98.14 | 2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Inari Medical, INC. | $80.22 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $71.60 | 2022-2023 | Diamondback Peripheral, Diamondback Coronary |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $58.69 | 2024 | Zio Xt Patch, Zio Monitor |
| Medtronic Vascular, INC. | $58.48 | 2019-2020 | |
| Angiodynamics, INC. | $55.71 | 2023-2025 | Auryon Laser System 100-120 Vac |
| E.R. Squibb & Sons, L.L.C. | $47.59 | 2020-2021 | |
| Stryker Corporation | $28.75 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $26.19 | 2025 | |
| Corcept Therapeutics | $24.05 | 2025 | Korlym |
| Organogenesis INC. | $19.33 | 2023 | Puraply |
| Kiniksa Pharmaceuticals International, Plc | $19.10 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $14.37 | 2021 | |
| Medtronic, INC. | $13.37 | 2021 | |
| Braemar Manufacturing, LLC | $11.38 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satish Sivasankaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.